arrow
R

Remond J.A. Fijneman

Netherlands Cancer Institute
H指数:45
被引数:9,770

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

TrialMatchAI: an end-to-end AI-powered clinical trial recommendation system to streamline patient-to-trial matching

TrialMatchAI: 一个端到端的人工智能临床试验推荐系统,简化患者与试验的匹配

2026-03-250
OAAI
Cancer-associated fibroblast signature and SMAD4 mutation in resistance to adjuvant chemotherapy in stage III colon cancer patients

III期结肠癌患者对辅助化疗耐药的癌症相关成纤维细胞特征和SMAD4突变

2026-01-310
OAAI
ASO Visual Abstract: Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases

ASO可视化摘要:循环肿瘤DNA对初始不可切除的RAS/RAF突变结直肠癌肝转移患者接受局部治疗后复发和生存的预后价值

2026-01-040
PRE
Circulating tumour DNA in patients with stage III colon cancer: multicentre prospective PROVENC3 study
2026-01-013
PRE
Prognostic Value of Circulating Tumor DNA for Recurrence and Survival in Patients Undergoing Local Treatment for Initially Unresectable RAS/RAF Mutated Colorectal Cancer Liver Metastases

循环肿瘤DNA对接受局部治疗的初始不可切除的RAS/RAF突变结直肠癌肝转移患者复发和生存的预测价值

2025-11-140
PRE
CtDNA-guided de-escalation of adjuvant chemotherapy in stage III colon cancer: early model-based evaluation of cost-effectiveness

CtDNA指导下的辅助化疗降级治疗在III期结肠癌中的应用:基于模型的早期成本效益评估

2025-11-060
OA
BLOODPAC's collaborations with European Union liquid biopsy initiatives

Dickey, J.; Katrivanos, E.; Leiman, L.; Abukhdeir, A.; Cardone, A.; Saritas-Yildirim, B.; Galamba, C.; Jankiewicz, C.; Rolfo, C.; Bhandari, D.; 等. BLOODPAC与欧盟液体活检倡议的合作. J. Liq. Biopsy 2025, 10, 100321. [Google Scholar] [CrossRef]

2025-09-010
OAAI
High Prevalence of Chromosomal Rearrangements and LINE Retrotranspositions Detected in Formalin-Fixed, Paraffin-Embedded Colorectal Cancer Tissue
2024-12-010
OAAI
First-line palliative systemic therapy alternated with oxaliplatin-based pressurized intraperitoneal aerosol chemotherapy for unresectable colorectal peritoneal metastases: A single-arm phase II trial (CRC-PIPAC-II)

一线姑息性全身治疗与基于奥沙利铂的加压腹膜内气雾剂化疗交替治疗不可切除的结直肠腹膜转移: 单臂II期试验 (crc-pipac-ii)

EJSO
IF2.9
2024-09-012
PRE
Early evaluation of the effectiveness and cost-effectiveness of ctDNA-guided selection for adjuvant chemotherapy in stage II colon cancer

ctDNA指导的 ⅱ 期结肠癌辅助化疗选择的有效性和成本-效果的早期评价

2024-08-212
OAAI
Monitoring treatment response in patients with metastatic colorectal cancer using cfDNA fragmentomics testing: The DOLPHIN trial
2024-03-220
PRE
Employing widening funds to address inequity in cancer research example of the STEPUPIORS collaborative rectal cancer project
2024-03-220
PRE